April 17 (Reuters) - The U.S. Food and Drug
Administration on Wednesday classified a recall of Boston
Scientific's ( BSX ) device used to block blood flow during
excessive bleeding or hemorrhaging as most serious.
The FDA said there were 11 incidents reported, seven
injuries, and two deaths related to the device's issue.